XDC Network, an enterprise-grade Layer 1 blockchain launched by XinFin in 2017, celebrates its 6th year since mainnet launch and 8 years of powering real-world blockchain adoption. Recognized for ...

Huerta’s advice won’t be binding but the presence of a social activist icon could be influential as OpenAI CEO Sam Altman attempts a costly restructuring of the San Francisco company's ...

XDC Network has introduced XDC.Cash, a next-generation payment platform powered by Encryptus, enabling users to convert XDC into fiat and alternative payments across 100+ countries.

XDC Network continues to strengthen its ecosystem with the launch of XDC.Cash, a Next-Generation Crypto Payment Solution powered by Encryptus. XDC holders can now convert their tokens into local ...

First to report this week was bioconjugate CRDMO WuXi XDC, which spun off from WuXi Biologics in 2023. Over the course of 2024, the company logged roughly 4.05 billion Chinese yuan ($559 million ...

The XDC coin’s value increased after it announced a partnership with DaoFin. XDC supports a hybrid platform of public and ...

XDC Network, the “enterprise-ready” blockchain for global trade finance and RWAs, is pleased to announce its collaboration with Deutsche Telekom MMS. Deutsche Telekom MMS is a subsidiary of ...

Since its launch in 2019, XDC Network, formerly known as XinFin Network, has been dedicated to solving real-world problems through innovative blockchain solutions. This focus on practical ...

WuXi XDC, which spun off from WuXi Bio And WuXi STA in November, has forged a partnership with the South Korean biotech IntoCell. As part of the pact, IntoCell will provide drug-linker ...

The operation was made possible through the collaboration of key technology providers, including XDC Trade Network, Propine, TradeFinex, and YodaPlus, all operating under the innovative TradeTrust ...

WuXi XDC is planning to sell 178.45 million in shares in an upcoming Initial Public Offering (IPO) in a bid to rake in 3.68 billion Hong Kong dollars ($470.5 million), according to a prospectus ...

WuXi XDC will provide end-to-end services to support Boostimmune’s discovery of novel bioconjugates. WuXi XDC, a contract research, development, and manufacturing organization (CRDMO), and Boostimmune ...